Akifumi Kushiyama - Concepedia

Author

Akifumi Kushiyama

The Institute of Medical Science, Asahi Life Foundation ORCID

Also Known As

A. Kushiyama, AKIFUMI KUSHIYAMA, Akifumi Kushiyama, Kushiyama Akifumi, Kushiyama, Akifumi, Yoshiaki Kubota

137

Publications

3.3K

Citations

H-Index

103

Concepts

All Affiliations

The Institute of Medical Science, Asahi Life Foundation Hiroshima University The University of Tokyo Nihon University University of Miyazaki

About

Akifumi Kushiyama is an author at The Institute of Medical Science, Asahi Life Foundation specializing in medicine, cell signaling, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	33	1.5K
2	Health Sciences	14	16	801
3	Biochemistry	14	14	800
4	Natural Sciences	9	9	482
5	Public Health	1	1	27

Akifumi Kushiyama

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
AMP-activated Protein Kinase Activation Increases Phosphorylation of Glycogen Synthase Kinase 3β and Thereby Reduces cAMP-responsive Element Transcriptional Activity and Phosphoenolpyruvate Carboxykinase C Gene Expression in the Liver Nanao Horike, Hideyuki Sakoda, Akifumi Kushiyama, Journal of Biological Chemistry Transcriptional RegulationSignal TransductionSignaling PathwayBiochemistryMolecular Regulation	2008	188
Oxidative stress induces insulin resistance by activating the nuclear factor-?B pathway and disrupting normal subcellular distribution of phosphatidylinositol 3-kinase Takehide Ogihara, Tomoichiro Asano, Hideki Katagiri, Diabetologia Metabolic RemodelingInsulin SignalingNuclear Factor-Oxidative StressMetabolic Syndrome	2004	146
Xanthine Oxidoreductase Is Involved in Macrophage Foam Cell Formation and Atherosclerosis Development Akifumi Kushiyama, Hirofumi Okubo, Hideyuki Sakoda, Arteriosclerosis Thrombosis and Vascular Biology	2011	122
Treatment with the SGLT2 inhibitor luseogliflozin improves nonalcoholic steatohepatitis in a rodent model with diabetes mellitus Shirong Qiang, Yusuke Nakatsu, Yasuyuki Seno, Diabetology & Metabolic Syndrome	2015	112
<i>Lactobacillus casei</i>strain Shirota protects against nonalcoholic steatohepatitis development in a rodent model Hirofumi Okubo, Hideyuki Sakoda, Akifumi Kushiyama, American Journal of Physiology-Gastrointestinal and Liver Physiology NutritionDysbiosisRodent ModelPathologyGut Microbiota	2013	101
The SGLT2 Inhibitor Luseogliflozin Rapidly Normalizes Aortic mRNA Levels of Inflammation-Related but Not Lipid-Metabolism-Related Genes and Suppresses Atherosclerosis in Diabetic ApoE KO Mice Yusuke Nakatsu, Hiroki Kokubo, Bumdelger Batmunkh, International Journal of Molecular Sciences ImmunologyNative Apoe KoHyperlipidemiaInflammationMetabolic Syndrome	2017	88
The xanthine oxidase inhibitor febuxostat suppresses development of nonalcoholic steatohepatitis in a rodent model Yusuke Nakatsu, Yasuyuki Seno, Akifumi Kushiyama, American Journal of Physiology-Gastrointestinal and Liver Physiology Metabolic DisorderRodent ModelPathologyFatty Liver DiseaseOxidative Stress	2015	83
Protective Effect of Sex Hormone-Binding Globulin against Metabolic Syndrome:<i>In Vitro</i>Evidence Showing Anti-Inflammatory and Lipolytic Effects on Adipocytes and Macrophages Hiroki Yamazaki, Akifumi Kushiyama, Hideyuki Sakoda, Mediators of Inflammation	2018	80
Adipocyte-macrophage interaction may mediate LPS-induced low-grade inflammation: Potential link with metabolic complications Hideo Nakarai, Akiko Yamashita, Shintaro Nagayasu, Innate Immunity	2011	77
Peptidyl-prolyl Cis/Trans Isomerase NIMA-interacting 1 Associates with Insulin Receptor Substrate-1 and Enhances Insulin Actions and Adipogenesis Yusuke Nakatsu, Hideyuki Sakoda, Akifumi Kushiyama, Journal of Biological Chemistry Glucose ToleranceInsulin SignalingMetabolic SyndromeSignaling PathwayReceptor Tyrosine Kinase	2011	65

Page 1